Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.

[1]  B. Mol,et al.  Surgical approach to hysterectomy for benign gynaecological disease. , 2015, The Cochrane database of systematic reviews.

[2]  F. Tu,et al.  Power morcellators: a review of current practice and assessment of risk. , 2015, American journal of obstetrics and gynecology.

[3]  C. Ananth,et al.  Uterine pathology in women undergoing minimally invasive hysterectomy using morcellation. , 2014, JAMA.

[4]  Karen C. Wang,et al.  In-bag morcellation. , 2014, Journal of minimally invasive gynecology.

[5]  Karen C. Wang,et al.  Risk of leakage and tissue dissemination with various contained tissue extraction (CTE) techniques: an in vitro pilot study. , 2014, Journal of minimally invasive gynecology.

[6]  M. Milad,et al.  Laparoscopic morcellator-related complications. , 2014, Journal of minimally invasive gynecology.

[7]  C. Nezhat,et al.  Evaluating the risks of electric uterine morcellation. , 2014, JAMA.

[8]  L. Lowenstein,et al.  Incidence of unanticipated uterine pathology at the time of minimally invasive abdominal sacrocolpopexy. , 2014, Journal of minimally invasive gynecology.

[9]  Alexander Schellong,et al.  Unexpected malignancies after laparoscopic-assisted supracervical hysterectomies (LASH): an analysis of 1,584 LASH cases , 2013, Archives of Gynecology and Obstetrics.

[10]  B. Quade,et al.  Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms , 2012, PloS one.

[11]  K. Kenton,et al.  Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction , 2012, International Urogynecology Journal.

[12]  V. Livolsi,et al.  Risk of Occult Malignancy in Morcellated Hysterectomy: A Case Series , 2011, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[13]  Sun-Kyung Park,et al.  The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. , 2011, Gynecologic oncology.

[14]  Aagl Advancing Minimally Invasive Gynecology Worldwide.  AAGL position statement: route of hysterectomy to treat benign uterine disease. , 2011, Journal of minimally invasive gynecology.

[15]  C. D. Della Badia,et al.  Endometrial stromal sarcoma diagnosed after uterine morcellation in laparoscopic supracervical hysterectomy. , 2010, Journal of minimally invasive gynecology.

[16]  M. Barber,et al.  Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. , 2010, American journal of obstetrics and gynecology.

[17]  R. Barakat,et al.  Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease , 2007, International Journal of Gynecologic Cancer.

[18]  Mitsuaki Suzuki,et al.  Risk of Complications and Uterine Malignancies in Women Undergoing Hysterectomy for Presumed Benign Leiomyomas , 1999, Gynecologic and Obstetric Investigation.

[19]  J. Berek,et al.  Uterine Sarcoma in Patients Operated on for Presumed Leiomyoma and Rapidly Growing Leiomyoma , 1994, Obstetrics and gynecology.

[20]  D. Mishell,et al.  Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. , 1990, American journal of obstetrics and gynecology.